Breaking News
Get 40% Off 0
⌛ Did you miss ProPicks’ 13% gains in May? Subscribe now & catch June’s top AI-picked stocks early. Unlock Stocks
Close

Bal Pharma Ltd (BALP)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
101.30 +1.50    +1.50%
- Closed. Currency in INR ( Disclaimer )
Type:  Equity
Market:  India
ISIN:  INE083D01012 
S/N:  BALPHARMA
  • Volume: 11,557
  • Bid/Ask: 100.50 / 101.30
  • Day's Range: 99.75 - 102.50
Bal Pharma Ltd 101.30 +1.50 +1.50%

Bal Pharma Ltd Company Profile

 
Get an in-depth profile of Bal Pharma Ltd, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryPharmaceuticals
SectorHealthcare
Employees

837

Equity Type

ORD

Bal Pharma Limited manufactures and markets pharmaceutical formulations and active pharmaceutical ingredients (APIs) in India, Uzbekistan, Guatemala, and Malta. The company offers prescription drugs, generics, OTC products, intravenous infusion products, and bulk actives. It provides anti-infectives, pain management, respiratory care, and women's health products under the Aziwin, Ebay, Balvibe, MNF, Ocium, and Monogesic Plus Gel brands; diabetic care products under the Diabend and Diabend M Group brands; herbal/ayurvedic preparations targeting conditions, such as prostate enlargement, renal calculi, male infertility, women health, etc. under the Stonex, Ashwamed, Prostowin, Suswas, Menoleap, and Ayursulin brands; anti-hypertensive, anti-lipidemic, and anti-obese products; skin care and bone health products; and cardiac care products under the Secremet and Servace brands. In addition, the company offers a range of APIs for therapeutic areas, such as anti-histamine, platelet inhibitor, anti-diabetic, anti-convulsant, urinary incontinence, neuropathic pain, anti-allergy, anti-inflammatory, diuretic, acne treatment, etc.; and various formulations. Further, it engages in the treatment of gastrointestinal disorders; and piles, fistula, and constipation. The company also exports its products. Bal Pharma Limited was incorporated in 1987 and is based in Bengaluru, India.

Contact Information

Address Lakshmi Narayan Complex 5th Floor
10/1, Palace Road Bengaluru,560052
India
Phone 91 80 4137 9500
Fax 91 80 2235 4057

Top Executives

Name Age Since Title
Shailesh Dheerajmal Siroya 55 1997 MD & Executive Director
Champion Venkateshalu Srinivas 55 2019 Non-Executive Independent Director
Jatish Sheth 65 2020 Additional Non-Executive Director
H. S. Venkatesh 66 2020 Non-Executive Additional Independent Director
Nicola Neeladri 43 2020 Independent Non-Executive Director
Kotian Chittananda Damodar - 2022 Additional Non-Independent Director
Himesh Virupakshaya 62 2019 Whole Time Director
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

BALP Comments

Write your thoughts about Bal Pharma Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Mritunjay Kumar
Mritunjay Kumar Apr 24, 2023 3:19AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
today 99 target only buy
SHRAWAN Raj
SHRAWAN Raj Nov 24, 2021 11:12PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
it will go 135 10dec
Abhishek Bhatt
Abhishek Bhatt Apr 20, 2021 12:24AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Will it go till 68-70
Akash Ahirwar
Akash Ahirwar Apr 20, 2021 12:24AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
it gone to 122 rupee in 3 weeks
Dinesh Prajapati
Dinesh Prajapati Jun 19, 2020 7:38AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
buy and hold.... it will grow very faster
Abhishek Bhatt
Abhishek Bhatt Jun 19, 2020 7:38AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
for how long
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email